Trial Profile
Short and Long-Term Electronic Surveillance of a Large Number of Healthcare Workers Following Administration of an Adjuvanted Ph1n1 Vaccine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus infections
- Focus Adverse reactions
- 13 Aug 2012 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 11 Feb 2011 New trial record